Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Cytotoxic T Lymphocytes
100%
Latent Viral Reservoir
100%
Virus Reactivation
100%
Highly Active Antiretroviral Therapy (HAART)
75%
Infected Cells
50%
Virus
25%
Viremia
25%
In Vitro Model
25%
Clinical Trials
25%
T Cell Activation
25%
Antigen-specific
25%
Latency
25%
Life-sustaining Treatment
25%
Provirus
25%
Latent Infection
25%
Resting CD4+ T Cells
25%
HIV-1 Replication
25%
Latent Reservoir
25%
Viral Cytopathic Effect
25%
Purging
25%
Latent HIV-1
25%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
T Lymphocyte
100%
Virus Reactivation
100%
Highly Active Antiretroviral Therapy
60%
Infection
20%
T-Helper Cell
20%
In Vitro
20%
Clinical Trial
20%
Provirus
20%
Antigen Specificity
20%
Viremia
20%
Cytopathogenic Effect
20%
T Cell Activation
20%
Rebound
20%
Immunology and Microbiology
T Cell
100%
Human Immunodeficiency Virus 1
100%
Virus Reactivation
100%
T-Helper Cell
20%
Viremia
20%
T Cell Activation
20%
Antigen Specificity
20%
Provirus
20%
Cytopathic Effect
20%
Rebound
20%